TP53 and breast cancer: Extending beyond breast cancer, higher TP53 mutation frequencies and lower PI3K pathway alterations among Black patients have also been observed in pan-cancer analyses, suggesting that such disparities may reflect broader biological patterns across malignancies47,48.